InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Whaley Glenn, Chief Financial Officer. Director active across 1 companies, notably Immunic, INC.. Aggregated, 4 reports have been logged. Total volume traded: €50k. The latest transaction was disclosed on 3 June 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€9,9133,500 shares@ €2.83230.0060% mcap19.9% of flow
Common Stock
SEC:0001193805-22-000918:0·
Ideal exit: 28 Feb 2023 (T+270)
€14,6833,000 shares@ €4.89420.0089% mcap29.5% of flow
Common Stock
SEC:0001193805-22-000788:0·
Ideal exit: 6 Feb 2023 (T+270)
€12,6031,500 shares@ €8.402100.0% of flow
Common Stock
SEC:0001193805-21-001163·
Ideal exit: 7 May 2022 (T+270)
€12,6031,500 shares@ €8.4020.0077% mcap25.3% of flow
Common Stock
SEC:0001193805-21-001163:0·
Ideal exit: 7 May 2022 (T+270)
4 of 4 declarations
About Whaley Glenn
Glenn Whaley is the Chief Financial Officer at Immunic, Inc. He oversees the financial operations of the company, including budgeting and risk management. His role is crucial in ensuring the financial health and growth of the company.
